StonvexLoading…
StonvexStonvexStonvexCore line items from MAS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $7.56B | $7.83B | $7.97B | $8.68B |
Operating Income | $1.25B | $1.36B | $1.35B | $1.30B |
Net Income | $810.00M | $822.00M | $908.00M | $844.00M |
EPS (Diluted) | $3.86 | $3.76 | $4.02 | $3.63 |
Total Assets | $5.20B | $5.02B | $5.36B | $5.19B |
Total Liabilities | $5.13B | $5.07B | $5.25B | $5.43B |
Cash & Equivalents | $647.00M | $634.00M | $634.00M | $452.00M |
Free Cash Flow OCF − CapEx | $866.00M | $907.00M | $1.17B | $616.00M |
Shares Outstanding | 204.30M | 212.50M | 220.60M | 225.30M |